Imunon (IMNN) CEO takes 6,615 shares instead of cash pay

Rhea-AI Filing Summary

Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. executive Stacy Lindborg, President and CEO, received an equity award of 6,615 shares of common stock on 2026-08-14. The shares were valued at $1.65 per share and were granted in lieu of cash for a portion of base salary. Following this grant, Lindborg directly holds 93,254 shares of Imunon common stock and indirectly holds an additional 778 shares through a 401(k) plan.

Insider Trade Summary

Net Buyer: 6,615 shares

Net Buy 2 txns

Insider Lindborg Stacy

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	6,615	$1.65	$11K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 93,254 shares (Direct); Common Stock — 778 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of base salary

Key Figures

Shares granted: 6,615 shares Grant reference price: $1.65 per share Direct holdings after transaction: 93,254 shares +1 more

4 metrics

Shares granted 6,615 shares Common stock grant on 2026-08-14 in lieu of cash salary

Grant reference price $1.65 per share Value per share for the 6,615-share stock grant

Direct holdings after transaction 93,254 shares Imunon common stock directly owned by Stacy Lindborg after the grant

Indirect 401(k) holdings 778 shares Imunon common stock held indirectly by 401(k) Plan

Key Terms

grant, award, or other acquisition, in lieu of cash, 401(k) Plan

3 terms

grant, award, or other acquisition financial

"transaction code description is "Grant, award, or other acquisition""

in lieu of cash financial

"Stock granted in lieu of cash for portion of base salary"

401(k) Plan financial

"nature_of_ownership is listed as "By 401(k) Plan""

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

What did Imunon (IMNN) report in Stacy Lindborg's latest Form 4?

Imunon (IMNN) reported that President and CEO Stacy Lindborg received an equity grant of 6,615 shares of common stock on 2026-08-14, at a reference value of $1.65 per share, in lieu of cash for part of base salary.

How many Imunon (IMNN) shares does Stacy Lindborg own after this transaction?

After the reported grant, Stacy Lindborg directly owns 93,254 Imunon shares and indirectly owns 778 shares through a 401(k) Plan, as disclosed in the Form 4 holdings section for non-derivative securities.

What was the size and price of the stock grant to Imunon (IMNN) CEO Stacy Lindborg?

Stacy Lindborg received a grant of 6,615 Imunon common shares at $1.65 per share. The filing notes this grant was provided in lieu of cash for a portion of base salary, indicating equity-based compensation rather than a market purchase.

Was the Imunon (IMNN) CEO’s new stock award a market purchase or compensation grant?

The reported transaction is a compensation grant, not a market purchase. The Form 4 describes the code A transaction as stock granted in lieu of cash for a portion of base salary, reflecting non-cash executive compensation.

Does Stacy Lindborg hold any Imunon (IMNN) shares indirectly?

Yes. In addition to directly held shares, Stacy Lindborg holds 778 Imunon shares indirectly by 401(k) Plan, according to the non-derivative holdings line reported as indirect ownership on the same Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 04:23 PM Accepted by SEC EDGAR 08/17/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindborg Stacy

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		A		6,615(1)	A	$1.65	93,254	D
Common Stock								778	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of base salary

	/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)